Bio Feedback Therapy for Peds

Biofeedback therapy is often a poorly understood discipline in medicine that may be beneficial for the primary care provider to be aware of. This is especially the case for pediatric populations that may need assistance with management of chronic pain conditions such as migraine, functional gastritis, tension headache, and some other musculoskeletal conditions that involve painful symptoms. Given the difficulty of long term management of chronic pain, especially in pediatrics, this modality is worth consideration in the picture of overall chronic pain management in the pediatric population.

Course•By NAPCP

Bridging Worlds: Integrating Indigenous Medicine and Naturopathic Primary Care

This lecture explores the integration of naturopathic medicine, acupuncture, and Indigenous healing practices to create culturally sensitive, patient-centered approaches for primary care. Drawing on years of experience working with Indigenous populations, this presentation will examine how traditional knowledge and practices—such as ceremonial healing, community-based support systems, and botanical medicine—can complement evidence-based medical care to address modern health challenges.

Course•By NAPCP

Cardiology Bundle

Brandon Testa, ND and Rachel Boone, ND

Course•By NAPCP

Common Pharmaceutical & Herb Interactions for the Medically Complex Pediatric Patient

The interaction of pharmaceuticals and herbs is often overlooked in many clinical settings. Understanding the basics of herb-drug interactions for commonly prescribed supplements and integrative medicines is important to help keep patients safe, particularly pediatric patients. This talk will explore common integrative therapeutics that can be prescribed by self-prescription, allied health professionals, or NDs alike and review current research on drug-herb interactions and information on safety monitoring.

Course•By NAPCP

Dietary Strategies for Hypertension Prevention and Management: Insights from Recent Systematic Review

The prevalence of hypertension globally necessitates effective prevention and management strategies, with dietary interventions playing a crucial role. This presentation synthesizes recent evidence, including a comprehensive umbrella review by Aljuraiban et al. (2024), to evaluate the efficacy of various dietary interventions in the prevention and treatment of hypertension. By critically assessing meta-analyses of both interventional and observational studies, we aim to delineate the quality of the evidence supporting specific dietary practices. Our review highlights the importance of considering bias, precision, and the magnitude of effects in interpreting study findings. Key dietary interventions discussed include the reduction of sodium intake and the potential benefits of the Mediterranean and DASH diets.

Course•By NAPCP

Encountering HIV in the Primary Care Setting

This presentation will cover the basics of HIV testing, diagnosis, treatment initiation, and infection prevention with PrEP for Primary Care Providers. We will cover screening guidelines, testing options, tips on having what can be challenging conversations for patients and providers alike, HIV diagnosis and treatment initiation, and discuss multiple options for PrEP (Pre-Exposure Prophylaxis) to help prevent HIV infection and protect our patients.

Course•By NAPCP

Guideline updates for GERD & Barrett's esophagus: What PCPs need to know

Last year (2022) brought two BIG guideline updates from the ACG on GERD and Barrett's esophagus evaluation and management. These guidelines provided much needed clarification on screening, diagnosis, and treatment recommendations, including identifying more clearly those patients who require long-term PPI treatment. This lecture will review the guidelines and implications for clinical practice, as well as discuss how a naturopathic primary care practice may differ from conventional guidelines and the rationale for such deviation.

Course•By NAPCP

Hematological Cancers in Primary Care

Lymphomas and leukemias can present earlier in life than other cancer types. Given that these groups of cancers are more treatable now, these patients are showing up more often in the primary care setting. Many have received cancer treatments that can have lasting effects on vital organs or increase risk of secondary cancers. This lecture will help the primary care provider to identify and support these individuals to optimize long term health and reduce the risk for a future cancer recurrence.

Course•By NAPCP

Herbal Approaches to Burnout: Supporting Resilience in Overwhelmed Patients

Burnout and chronic stress-related disorders are increasingly prevalent in primary care settings, affecting patients across diverse demographics. As these conditions contribute to emotional exhaustion, reduced physical resilience, and HPA (hypothalamic-pituitary-adrenal) axis dysregulation, primary care providers must adopt integrative strategies to restore balance and promote resilience.

Course•By NAPCP

High Risk Hypercholesterolemias and Lp(a) Management: Non-Statin Pharmacology

Cardiovascular disease continues to be the leading cause of death in the United States. About 1:250 people in the US have heterozygous familial hypercholesterolemia and about 20% of Americans have an elevated Lp(a). Although statins continue to be foundational to primary and secondary prevention of ASCVD in all patients, there are several newer medications such as ezetimibe, PCSK9 inhibitors, inclisiran, and bempedoic acid that are highly effective and underutilized. Patients may not tolerate statins or may require multiple pharmacologic agents to reach their treatment targets, especially in the context of familial hypercholesterolemia. Therefore, a strong understanding of these medications and when to prescribe them is an essential part of the latest, evidence-based ASCVD treatment approach.

Course•By NAPCP

Managing Perinatal and Postpartum Mood Disorders

Mental healthcare for pregnant and postpartum patients is an important opportunity to set a family up for successful emotional attachment and parenting. In this seminar, we will cover the evaluation tools for perinatal mood disorders, botanical interventions that do not interfere with pregnancy or lactation, and appropriate psychiatric medication.

Course•By NAPCP

Mental Health Bundle

Jayne DuBois, ND and Molly McDonnell PMHNP-BC, ARNP

Course•By NAPCP

NAFLD's got a new name! MASLD Diagnosis & Management Guideline Updates

2023 brought with it a BIG guideline update from the American Association for the Study of Liver Diseases (Rinella, et al. 2023) on the condition previously known as non-alcoholic Fatty Liver Disease (NAFLD). NAFLD, which is estimated to impact up to 25% of the US population, has been an area of intensive research since the prior published guidelines in 2018. This newest publication provides substantive updates to the best practices for evaluation and management of the newly re-named Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) (Rinella, Lazarus, et al. 2023). This lecture will review the guidelines and implications for clinical practice, with special focus on the newest recommendations regarding the use of biomarkers and other non-invasive tests for diagnosis and management of NAFLD/MASLD, as well as when referral to higher levels of care would be appropriate.

Course•By NAPCP

Pelvic Inflammatory Disease: Diagnosis and Management in the Primary Care Setting

Pelvic Inflammatory Disease (PID) is estimated to affect approximately 1 million individuals in the United States each year, but diagnosis is often delayed or missed due to mild or non-specific symptoms or atypical presentation. Underdiagnosis increases the risk of long-term sequelae including infertility, ectopic pregnancy, and chronic pelvic pain. Mild and moderate cases of PID can be managed outpatient in the primary care setting and primary care providers should be comfortable diagnosing and treating this condition. This presentation will review PID signs and symptoms, diagnostic criteria, etiological agents, and patient management.

Course•By NAPCP

Prescribing Medications for Opioid Use Disorder

This lecture serves to review medications that are utilized in treatment of opioid use disorder mainly focusing on buprenorphine, with a very brief overview of naltrexone and methadone. This will provide high-yield prescribing recommendations for starting, maintaining, and tapering buprenorphine. The lecture will be given largely in case-based examples with structured evidence-based data to help guide prescribers feel more comfortable with this life-saving medication.

Course•By NAPCP

Rheumatology Updates 2024

Review updates and evolving developments in rheumatology classification criteria, treatments and preventative care for immunosuppressed patients

Course•By NAPCP

RSV Vaccine Update

Review the newly approved RSV immunizations, eligible populations, and best practices.

Course•By NAPCP

Screening and Management of Alcohol Use Disorders

The purpose of this presentation is to provide education on how to screen for alcohol use disorder properly and effectively as a primary care provider. This will include the establishment of rapport, identifying co-morbidities and risk factors, and the proper use of screening tools such as the CAGE questionnaire, T-ACE, AUDIT, and AUDIT-C. Additionally, we will cover appropriate screenings for red flags such as withdrawal, seizures, delirium tremens, and proper care coordination. Other topics in this presentation will include common nutrient deficiencies, medical and psychiatric co-morbidities, patient education, prognostic factors, and practitioner limitations. We will also review how to properly record and assess the number of drinks per week and key points in documentation with appropriate coding.

Course•By NAPCP

Syphilis Testing and Treatment for the PCP + Doxy PEP

Two part lecture: 1) T palladium epidemiology, testing/interpretation, treatment and monitoring 2) Doxy PEP prescribing for STI prophylaxis

Course•By NAPCP

The ABCs of Hepatitis

From the perspective of clinicians in a diverse primary care settings, the most important elements of the three most common hepatitis will be reviewed. Included will be diagnosis, evaluation, indications for treatment, pharmacology, and review of the evidence of nutraceutical and botanicals.

Course•By NAPCP

Treatment of (sub-clinical) Atherosclerosis Beyond Statins

Atherosclerosis is a chronic inflammatory disease and is the underlying cause of death in about 50% of people living in westernized countries. As a primary care provider we see patients on a daily basis who have atherosclerosis, and we can provide them evidence guided treatments that modify their life and health span. The goal of my lecture is to review current research, practice guidelines, and evidence guided treatments to help stabilize, reduce progression, and where possible reverse atherosclerotic plaques. At the conclusion of the conversation you will walk away with practice ready and primary care level interventions using pharmaceutical, botanical/nutraceutical, and diet/lifestyle treatments.

Course•By NAPCP

Treatment of Mast Cell Activation Disorders

Course•By NAPCP

You’re in Control: A Primer on Practical, Ethical, and Safety Considerations When Prescribing Controlled Substances

With the continued growth of naturopathic licensure and scope, Naturopathic Physicians in many states now have access to a broad range of treatments to help patients, in the form of the full range of pharmacotherapies available to our conventional colleagues. Any treatment, of course, is not without its risks, and the "controlled substances" carry not only medical but also legal and ethical risks. This lecture will review the different DEA schedules of controlled substances, many of the common medication classes covered (specifically opioids, stimulants, and sedative-hypnotics), as well as how to safely prescribe. In addition, recommendations will be made for safely, ethically, and legally prescribing these medications, to protect both the patient and one's practice.

Course•By NAPCP